Singh, U., Zadorozhny, V., Farrington, L., Bell, K., Borzillo, G. V., Shen, F., McCarthy, S., Varela, C. R., Schaeffer, D., Mundle, S. D., Li, Y. (., Ng, T. (., Wang, S. (2026). Clinical validity of FoundationOne CDx assay to identify
                    <i>HRR</i>
                    -positive or
                    <i>BRCA</i>
                    -positive mCSPC patients in the phase 3 AMPLITUDE study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.166